Yes, Tumor Lysis Syndrome Can Occur Without Any Cancer Treatment
Yes, this patient can absolutely develop tumor lysis syndrome even without receiving any cancer treatment—this is called spontaneous tumor lysis syndrome (STLS), and while less common than treatment-induced TLS, it is a well-recognized oncologic emergency that occurs in certain high-risk malignancies. 1
Understanding Spontaneous TLS
While TLS is most frequently observed after initiation of cytotoxic therapy, the guidelines explicitly state that it may occur spontaneously and/or in other tumor types with a high proliferative rate, large tumor burden, or high sensitivity to cytotoxic therapy 1. This is not a theoretical concern—multiple case reports document STLS in both hematologic malignancies and solid tumors 2, 3, 4, 5, 6.
High-Risk Features for Spontaneous TLS
Your patient should be evaluated for these specific risk factors that predispose to STLS:
Disease-Related Factors (Highest Risk):
- Bulky disease (especially bulky small cell lung cancer or massive liver metastases)
- High-grade lymphomas (particularly Burkitt's lymphoma and T-cell lymphoblastic NHL)
- Acute lymphoblastic leukemia in adults
- Elevated LDH >2× upper normal limit
- Metastatic germ cell tumors 7
Host-Related Factors:
- Pre-existing renal impairment
- Dehydration
- Obstructive uropathy
- Hyperuricemia (>8 mg/dL in children, >10 mg/dL in adults) 7
Clinical Context from Case Reports
Recent literature demonstrates STLS can occur in:
- Small cell lung cancer presenting with dyspnea and oliguria 3
- Metastatic pancreatic adenocarcinoma presenting with fatigue and metabolic derangements 5
- Advanced ovarian carcinoma presenting with abdominal distension and acute kidney injury 6
- Hematologic malignancies as the first presenting symptom 4
Critical Action Points
Immediate evaluation should include:
- Creatinine clearance or estimated GFR
- Serum LDH levels
- Renal ultrasound to exclude obstructive uropathy
- Complete metabolic panel looking for hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia
- Uric acid level 7
If STLS is suspected or the patient is high-risk:
- Begin aggressive IV hydration immediately (≥2 L/m²/day)
- Target urine output ≥100 mL/hour in adults
- Consider prophylactic rasburicase 0.20 mg/kg/day for high-risk patients
- Monitor electrolytes closely
- Do NOT alkalinize urine (this recommendation has been abandoned) 1, 7
Important Caveats
The key pitfall is assuming TLS only occurs after chemotherapy. Clinicians must maintain a high index of suspicion for STLS when patients with high tumor burden present with:
- Acute kidney injury
- The classic electrolyte constellation (hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia)
- Elevated LDH
Even in solid tumors traditionally considered "low-risk" for TLS, spontaneous cases have been documented when tumor burden is massive and proliferation rate is high 2, 5, 6. The syndrome can develop from diagnostic procedures like liver biopsy in high-burden disease 8.
Recognition of risk factors, vigilant monitoring, and appropriate prophylactic interventions are essential 1. The potential severity of complications requires immediate action even before treatment begins if risk factors are present.